Abstract
Aim:
To investigate the mechanisms underlying the intestinal absorption of the major bioactive component forsythoside A (FTA) extracted from Forsythiae fructus.
Methods:
An in vitro Caco-2 cell model and a single-pass intestinal perfusion in situ model in SD rats were used.
Results:
In the in vitro Caco-2 cell model, the mean apparent permeability value (Papp-value) was 4.15×10-7 cm/s in the apical-to-basolateral (AP-BL) direction. At the concentrations of 2.6–10.4 μg/mL, the efflux ratio of FTA in the bi-directional transport experiments was approximately 1.00. After the transport, >96% of the apically loaded FTA was retained on the apical side, while >97% of the basolaterally loaded FTA was retained on the basolateral side. The Papp-values of FTA were inversely correlated with the transepithelial electrical resistance. The paracellular permeability enhancers sodium caprate and EDTA, the P-gp inhibitor verapamil and the multidrug resistance related protein (MRP) inhibitors cyclosporine and MK571 could concentration-dependently increase the Papp-values, while the uptake (OATP) transporter inhibitors diclofenac sodium and indomethacin could concentration-dependently decrease the Papp-values. The intake transporter SGLT1 inhibitor mannitol did not cause significant change in the Papp-values. In the in situ intestinal perfusion model, both the absorption rate constant (Ka) and the effective permeability (Peff-values) following perfusion of FTA 2.6, 5.2 and 10.4 μg/mL via the duodenum, jejunum and ileum had no significant difference, although the values were slightly higher for the duodenum as compared to those in the jejunum and ileum. The low, medium and high concentrations of verapamil caused the largest increase in the Peff-values for duodenum, jejunum and ileum, respectively. Sodium caprate, EDTA and cyclosporine resulted in concentration-dependent increase in the Peff-values. Diclofenac sodium and indomethacin caused concentration-dependent decrease in the Peff-values. Mannitol did not cause significant change in the Papp-values for the duodenum, jejunum or ileum.
Conclusion:
The results suggest that the intestinal absorption of FTA may occur through passive diffusion, and the predominant absorption site may be in the upper part of small intestine. Paracellular transport route is also involved. P-gp, MRPs and OATP may participate in the absorption of FTA in the intestine. The low permeability of FTA contributes to its low oral bioavailability.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Liu Y, Hu M . Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perfused rat intestinal model. Drug Metab Dispos 2002; 30: 370–7.
Helen Chan O, Sinz MW, Stewart BH . Multiple-model evaluation of absorption of a tachykinin receptor antagonist. Adv Drug Deliv Rev 1997; 23: 121–31.
Artursson P, Palm K, Luthman K . Caco-2 monolayers in experimental and the oretical predictions of drug transport. Adv Drug Deliv Rev 2001; 46: 27–43.
Hidalgo IJ, Li J . Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Adv Drug Deliv Rev 1996; 22: 53–66.
Wang XD, Meng MX, Gao LB, Liu T, Xu Q, Zeng S . Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm 2009; 378: 1–8.
Yu LS, Zeng S . Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2. J Pharm Pharmacol 2007; 59: 655–60.
Painc MF, Fisher MB . Immunochemical identification of UGT isoforms in human small bowel and in Caco-2 cell monolayers. Biochem Biophys Res Commun 2000; 273: 1053–7.
Bohets H, Annaert P, Mannens G, Van Beijsterveldt L, Anciaux K, Verboven P, et al. Strategies for absorption screening in drug discovery and development. Curr Topic Med Chem 2001; 1: 367–83.
Zuo Z, Zhang L, Zhou LM, Chang Q, Chow M . Intestinal absorption of hawthorn flavonoids — in vitro, in situ and in vivo correlations. Life Sci 2006; 79: 2455–62.
State Pharmacopoeia Committee, 2010. Chinese Pharmacopoeia, vol.1, Beijing: Chemical Industry Press; 2010. p159.
Zhang LW . Extraction method, and biological activities of forsythiaside. Taiyuan: Shanxi University; 2002.
Wang GN, Pan RL, Liao YH, Chen Y, Tang JT, Chang Q . An LC-MS/MS method for determination of forsythiaside in rat plasma and application to a pharmacokinetic study. J Chromatogr B 2010; 878: 102–6.
Lu WG, Wang LL, Chen TT, Yu LF, Yang YJ, inventors; Shang ZX. Patent Agent LTD, assignee. One forsythiaside combination. China patent CN101919869A. 2010 Dec 22.
Zornoza T, Cano-Cebrian MJ, Nalda-Molina R, Guerri C, Granero L, Polache A . Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO–2 cell monolayers) and in vivo models. Eur J Pharm Sci 2004; 22: 347–56.
Du Q, Di LQ, Shan JJ, Liu TS, Zhang XZ . Intestinal absorption of daphnetin by rats single pass perfusion in situ. Acta Pharm Sin 2009; 44: 922–6.
Walgren RA, Karnaky KJ Jr, Lindenmayer GE, Walle T . Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein–2. J Pharmacol Exp Ther 2000; 294: 830–6.
Wolffram S, Block M, Ader P . Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. Biochem Mol Action Nutr 2002; 1: 630–5.
Ma G . Study on absorptive mechanism and modulation of Hawthorn Leaves Flavonoids [D]. Chengdu: Sichuan University; 2007.
Kusuhara H, He Z, Nagata Y, Nozaki Y, Ito T, Masuda H, et al. Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus. Pharm Res 2003; 20: 720–7.
Wang L . Preparation of feisuoweima double-layer sustained release tablets and studies on fexofenadine hydrochloride intestinal absorption in rat in vitro [D]. Shengyang: Shengyang Pharmaceutical University; 2003.
Deli MA . Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta 2009; 1788: 892–910.
Lindmark T, Kimura Y, Artursson P . Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 1998; 284: 362–9.
Zhou W, Di LQ, Shan JJ, Bi XL, Chen LT, Wang LC . Intestinal absorption of forsythoside A in different compositions of Shuang-Huang-Lian. Fitoterapia 2011; 82: 375–82.
Konishi Y, Hagiwara K, Shimizu M . Transepithelial transport of fluorescein in Caco-2 cell monolayers and its use in in vitro evaluation of phenolic acids availability. Biosci Biotech Biochem 2002; 66: 2449–57.
Salama NN, Eddington ND, Fasano A . Tight junction modulation and its relationship to drug delivery. Adv Drug Delivery Rev 2006; 58: 15–28.
Zornoza T, Cano-Cebrián MJ, Nalda-Molina R, Guerri C, Granero L, Polache A . Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (Caco-2 cell monolayers) and in vivo models. Eur J Pharm Sci 2004; 24: 347–56.
Ping QN, editors. Gastrointestinal transport and pharmaceutical designation of ingredients in Chinese medicine. Beijing: Chemical Industry Press; 2010. p 257.
Rodrigues AC, Curi R, Genvigir FD, Hirata MH, Hirata RD . The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells. Acta Pharmacol Sin 2009; 30: 956–64.
Pinto M, Robine-Leon S, Appay MD . Enterocyte-like differentiation and polarization of the human colon carcmoma cell line Caco-2 in culture. Biol Cell 1983; 47: 323–30.
Artursson P . Epithelial transport of drugs I. A model for studying the transport of drugs (β-blocking agents) over an intestinal epithelial cell line (Caco-2). J Pharm Sci 1990; 79: 476–82.
Zhou W, Di LQ, Bi XL, Chen LT, Du Q . Intestinal absorption of forsythoside A by rat circulation in situ. Acta Pharm Sin 2010; 45: 1373–8.
Rinaki E, Dokoumentzidis A, Valsami G, Macheras P . Identification of biowaivers among class II drugs: theoretical justification and practical examples. Pharm Res 2004; 21: 1567–72.
Sachan NK, Bhattacharya A, Pushkar S, Mishra A . Biopharmaceutical classification system: A strategic tool for oral drug delivery technology. Asian J Pharm 2009; 3: 76–81.
Gao Y, He L, Katsumi H, Sakane T, Fujita T, Yamamoto A . Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Int J Pharm 2008; 359: 70–8.
Lindmark T, Kimura Y, Artursson R . Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 1998; 284: 362–9.
Motlekar NA, Srivenugopal KS, Wachtel MS, Youan BC . Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation. J Pharm Pharmacol 2006; 58: 591–8.
Motlekar NA, Srivenugopal KS, Wachtel MS, Youan BB . Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer. Drug Develop Res 2006; 67: 166–74.
Huang JG, Si LQ, Jiang LL, Fan Z, Qiu J, Li G . Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism. Int J Pharm 2008; 356: 351–3.
Jain R, Duvvuri S, Kansara V, Mandava NK, Mitra AK . Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats. Int J Pharm 2007; 336: 233–40.
Acknowledgements
The present study was supported financially by the “Qing Lan” Project from Jiangsu Provincial Technology Innovation Team Support Scheme, the priority Academic Program Development of Jiangsu Higher Education Institution (No ysxk-2010) and 2012 program sponsored for scientific innovation research of college graduate in Jiangsu province (623).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, W., Di, Lq., Wang, J. et al. Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models. Acta Pharmacol Sin 33, 1069–1079 (2012). https://doi.org/10.1038/aps.2012.58
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2012.58
Keywords
This article is cited by
-
Pretreatment with broad-spectrum antibiotics alters the pharmacokinetics of major constituents of Shaoyao-Gancao decoction in rats after oral administration
Acta Pharmacologica Sinica (2019)
-
Phorbol 12-myristate 13-acetate inhibits P-glycoprotein-mediated efflux of digoxin in MDCKII-MDR1 and Caco-2 cell monolayer models
Acta Pharmacologica Sinica (2014)
